Not exact matches
«
When your
brain is firing off these synapses
of anger, you're weakening your immune system; you're raising your blood pressure, increasing your risk
of heart
disease, obesity and diabetes, and a plethora
of other negative ailments,» he says.
This
disease occurs
when blood flow to a region
of the
brain is interrupted by either a clot or bleeding, depriving the body
of oxygen and nutrients.
«I don't know for sure, but I've heard several senators say that Ted Kennedy with a
brain tumour, being 77 years old as opposed to being 37 years old, if he were in England, would not be treated for his
disease, because end
of life -
when you get to be 77, your life is considered less valuable under those systems,» he said.
While they don't have definite answers, besides having good genes, Kawas said, the answer is probably a combination
of being resilient to Alzheimer's
Disease and also that they did not develop other dementia - causing conditions, such as microscopic infarctions that occur
when blood flow is blocked from certain regions
of the
brain and hippocampal sclerosis, which causes neuron loss.
«Steep funding cuts for the federal health agencies are counterproductive at a time
when innovative research is moving us closer to identifying solutions for rare
diseases, new prevention strategies to protect Americans from deadly and costly conditions, advances in gene therapy, new technologies for understanding the
brain, and treatments that harness the ability
of our immune system to fight cancer.»
Stanford University researchers studying how the
brain controls movement in people with paralysis, related to their diagnosis
of Lou Gehrig's
disease, have found that groups
of neurons work together, firing in complex rhythms to signal muscles about
when and where to move.
The new study is an example
of what happens
when epidemiology experiments — studies
of patterns in health and
disease — crash into studies
of brain imaging.
Brain - based computers could help emergency department doctors render elusive diagnoses even
when science has yet to recognize the collection
of changes in body temperature, blood composition or other variables associated with an underlying
disease.
Rats with Alzheimer's
brain plaques go on to develop additional signs
of the
disease when they are given nicotine
That's part
of the challenge for clinicians who may not be familiar with ALD: «How do you know
when this is a critical
brain disease versus just a normal part
of development?»
«This shows how important it is to implement different
brain regions into in vitro models, especially
when studying how neurological
diseases impact connected regions
of the
brain.»
When we suppressed the ALS mutation in the
brains of animals, onset
of the
disease was delayed, the animals lived longer, spinal motor neurons survived longer, and the neuromuscular junctions stayed healthy longer,» said Svendsen, the Kerry and Simone Vickar Family Foundation Distinguished Chair in Regenerative Medicine.
Saatchi, which is owned by France's Publicis Groupe, SA, chose LifeStraw over a field
of competitors that included a reusable controller to improve the distribution
of IV fluids, a collapsible wheel that can be folded down for easier storage
when not in use on bicycles or wheelchairs, an energy - efficient laptop designed for children in developing countries, a 3 - D display that uses special optics and software to project a hologramlike image
of patient anatomy for cancer treatment, an inkjet printing system for fabricating tissue scaffolds on which cells can be grown, a visual prosthesis for bypassing a
diseased or damaged eye and sending signals directly to the
brain, books with embedded sound tracks to help educate illiterate adults on health issues, a phone that provides telecommunications coverage to poor rural populations in developing countries, and a
brain - computer interface designed to help paralyzed people communicate via neural signals.
The guidelines provide parameters regarding
when clinicians should consider the possibility
of ventriculitis (inflammation
of the ventricles in the
brain) or meningitis (inflammation
of the lining
of the
brain or spinal cord) in patients who have cerebrospinal fluid shunts and drains (devices placed in the
brain to relieve pressure due to fluid buildup), intrathecal drug pumps (for administration
of pain medicine or other drugs into the spinal canal), deep
brain stimulation hardware (medical devices that provide electrostimulation in the
brain to treat Parkinson's
disease or other neurological symptoms) or who have undergone neurosurgery or suffered from head trauma.
An FDA approved drug to treat renal cell carcinoma appears to reduce levels
of a toxic
brain protein linked to dementia in Alzheimer's and Parkinson's
diseases when given to animals.
«But perhaps the most exciting implication is that our tools,
when paired with appropriate activity modulator genes, could enable non-invasive deep
brain modulation for the treatment
of neurological
diseases such as Parkinson's
disease.»
When the prion was injected into the
brains of mice, the
brains became spongy and riddled with holes, the telltale signs
of prion
disease.
Hepatic encephalopathy occurs
when the liver can not remove certain toxins and chemicals, such as ammonia, from the blood.1 These toxins and chemicals then build up and enter the
brain.1 Hepatic encephalopathy is one
of the major complications
of cirrhosis (scarring
of the liver), and a leading cause
of hospital re-admission due to its recurrence, despite treatment.1 It can occur suddenly in people with acute liver failure, but is seen more often in those with chronic liver
disease.1 Symptoms
of hepatic encephalopathy include mild confusion, forgetfulness, poor concentration and personality or mood changes, but can progress to extreme anxiety, seizures, severe confusion, jumbled and slurred speech and slow movement.1 The first step in treatment is to identify and treat any factors that cause hepatic encephalopathy.2 Once the episode has resolved, further treatment aims to reduce the production and absorption
of toxins, such as ammonia.1 Generally, there are two types
of medication used to reduce the likelihood
of another hepatic encephalopathy episode — lactulose and rifaximin.2 However, it remains a leading cause
of hospitalisations and re-hospitalisations in cirrhotic patients, despite the use
of the above - mentioned standard
of care treatment.
But
when the enzymes are over-activated, the
brain produces an excessive level
of neurotoxic byproducts, causing neuronal dysfunctions that lead to psychiatric disorders and neurodegenerative
diseases.
When we think
of Parkinson's
disease, we often focus on its motor symptoms, such as stiffness and trembling, which are caused by a gradual decrease in the dopamine supply to a
brain area called the striatum, the primary input nucleus
of the basal ganglia.
The recent ability to peer into the
brain of living individuals with a rare type
of language dementia, primary progressive aphasia (PPA), provides important new insights into the beginning stages
of this
disease — which results in language loss —
when it is caused by a buildup
of a toxic protein found in Alzheimer's
disease.
When these motor neurons die, the
brain can no longer control muscle movements; in the later stages
of the
disease, patients become totally paralyzed.
«It's critically important to be able to look at questions
of brain development in real human tissue
when you're trying to study human
disease.
They used state -
of - the - art DNA sequencing technology to screen for retrotransposons in tissue samples taken postmortem from three individuals who were healthy
when alive and had no neurological
disease or signs
of abnormality in their
brain tissue.
An unpredictable
disease that disrupts the flow
of information within the
brain and between the
brain and the body, MS is triggered
when the immune system attacks the myelin sheath, the protective covering around the axons
of nerve fibers.
Foundation supports innovative research designed to bring science closer to the day
when diseases of the
brain can be accurately diagnosed, prevented, and treated.
When this vasculature — the blood -
brain barrier (BBB)-- ruptures, blood proteins can enter into the
brain and cause edema and neuronal damage in a variety
of neurological
diseases, such as stroke, multiple sclerosis, Alzheimer's
disease, and spinal cord injury.
That broth far outperformed others created from the
brains of people who had shown no signs
of dementia
when they died, or even from regions
of the
diseased brains that didn't have the plaques.
He had examined the
brain of a woman with serious dementia
when she died and described two distinct abnormalities, now recognized as the plaques and tangles that are characteristic
of the
disease.
Raichle's observation
of patterns
of ongoing
brain activity
when the subject is in a resting state, or
when the
brain is not actively engaged in performing tasks such as recalling events or learning new words, has transformed the way the human
brain is now being studied in health and
disease.
These studies are yielding novel ways to keep this network functional
when relevant
brain cells and chemicals are lost as a result
of the
disease.
The massive number
of cells within the OSVZ
of humans «tells us we have to be careful
when modeling human
brain diseases in mice,» says Kriegstein.
LA JOLLA, CA — Glioblastoma, the most common and lethal form
of brain cancer and the
disease that killed Massachusetts Senator Ted Kennedy, resists nearly all treatment efforts, even
when attacked simultaneously...
Health improvement (allowing to post - pone / escape the
diseases and thus live, healthier /
disease - free longer, but not above human MLSP
of around 122 years; thus these therapies do not affect epigenetic aging whatsoever, they are degenerative aging problems not regular healthy aging problem (except OncoSENS - only
when you Already Have Cancer - which cancer increases epigenetic aging, but cancer removal thus does not change anything / makes no difference about what happens in the other cells / about what happens in the normal epigenetic «aging» course in Normal non-cancerous healthy cells) Although there is not such thing as «healthy aging» all aging in «unhealthy» (as seen from elders who are «healthy enough» who show much damage), it's just «tolerable / liveable» enough (in terms
of damage accumulating) that it does not affect their quality
of life (enough yet), that is «healthy aging»: ApoptoSENS - Clearing Senescent Cells (this will have great impact to reduce
diseases, the largest one, since it's all inflammation fueled by the inflammation secretory phenotype (SASP)
of these senescent cells) AmyloSENS - Dissolving the Plaques (this will allow humans to evade Alzheimer's, Parkinsons and general
brain degenerescence, allowing quite a boost; making people much more easily reach the big 100 - since the
brain is causal to how long we live; keeping
brain amyloid - free and keeping our memories / neuron sharp / means longer LongTerm Potentiation - means longer
brain function means longer heavy
brain mass (gray matter / white matter retention seen in «sharp - witted» Centenarians who show are younger
brain for their age), and both are correlated to MLSP).
Sure enough,
when the researchers examined the
brains of PD patients, they found more cells exhibiting signs
of senescence than in people without the
disease — and especially astrocytes, as they had expected.7 This was true even after matching patients for age, meaning that PD subjects had even more senescent astrocytes in their SNcs than is typical for people their age (ranging in this case from 50 — 92 years at autopsy)-- and remember, aging already drives an increase in the burden
of these cells as compared with young people, even in those who have yet to develop Parkinson's
disease.7
Both recent experience with immunotherapy for clearance
of Aβ in AD, and their own (and Prothena's) experience with AS - clearing immunotherapies in animal models, indicate that in order to be effective as
disease - modifying agents
when administered alone, therapies that remove proteinaceous aggregates from the
brain must be initiated in the early clinical or even preclinical stages
of the
disease, before the burden
of other forms
of aging damage becomes entrenched.
So
when AFFiRiS» Schneeberger opines that «given the mode
of action
of disease modifiers», an AS - clearing immunotherapy such as PD01A (or PRX002) is «really something we need to apply early in this
disease» because «once the the
brain cells are destroyed, getting them back is probably impossible,» he is adopting a view that is entirely reasonable — but only because it is constrained to the specific plank in the integrated platform that rejuvenation biotechnology must become.
For screening and clinical management, and for clinical trials, it would be extremely useful to be able to monitor the pathological progression
of Alzheimer's
disease (AD), especially during the decades preceding the onset
of clinical symptoms
when AD spreads silently in the
brain.
When Mark Goldberg, M.D., joined UT Southwestern's Department
of Neurology in 2010 as Chair, one
of his initial acts was to change the department's name to «Neurology and Neurotherapeutics» — a move that acknowledged the department's mission to seek effective treatments for
brain diseases.
A
disease which manifests
when the dopamine - producing nerve cells in the
brain are damaged and thus produce less and less
of this important chemical.
These interests grew from studies
of paraneoplastic neurologic disorders (PNDs), a group
of diseases thought to arise
when tumors — typically breast, ovarian, or lung cancers — start making proteins normally only made by the
brain.
Three recent experimental studies focused on low consumption / exposure.949596 In one study, 29 smokers each consumed a single cigarette, immediately after which they had a significant decrease in blood vessel output power and significant increase in blood vessel ageing level and remaining blood volume 25 minutes later, as markers
of atherosclerosis.94 In another study, human coronary artery endothelial cells were exposed to the smoke equivalent to one cigarette, which led to activation
of oxidant stress sensing transcription factor NFR2 and up - regulation
of cytochrome p450, considered to have a role in the development
of heart
disease.95 These effects were not seen
when heart cells were exposed to the vapour from one e - cigarette.95 A study exposed adult mice to low intensity tobacco smoke (two cigarettes) for one to two months and found adverse histopathological effects on
brain cells.96
«
When we saw how much inhibiting PLSCR1 reduced the inflammatory response, we immediately wondered if this mechanism could apply more broadly, not just to virus infection
of the
brain, but to other types
of infections or even autoimmune
diseases,» says Yusuf Tufail, a former Salk postdoctoral fellow and first author
of the paper.
One
of the challenges researchers face
when developing treatments for Alzheimer's
disease is that the patients are elderly, which means their
brains are less plastic and more resistant to rewiring.
Parkinson's
Disease (PD) manifests
when the dopamine - producing nerve cells in the
brain are damaged and thus produce less and less
of this important chemical.
It may stave off dementia Among patients with mild Alzheimer's
disease (age 60 and older), those with lower physical fitness levels (measured by cardiovascular tests on a treadmill) had four times more
brain shrinkage
when compared to normal adults than those who were more physically fit, according to a recent study from the University
of Kansas School
of Medicine.
Glaucoma is actually a series
of diseases that damage the optic nerve (the nerve that connects the retina
of the eye to the
brain), often
when too much pressure is put on the eye due to fluid buildup.
«Finding this association with a strong marker
of Alzheimer's
disease risk reinforces the idea that being underweight as you get older may not be a good thing
when it comes to your
brain health,» he added.
Another autoimmune
disease, multiple sclerosis (MS) occurs
when the immune system attacks the body's own nerve cells and disrupts communication between the
brain and the rest
of the body.
According to Akira Yagi, professor at Fukuyama University, extracts
of aloe may even improve signs
of Alzheimer's
disease and some forms
of dementia,
when the
brain has become insulin - resistant.